BMC Cancer

1. TAKAHASHI N, Hara H, Nagashima K, Hirata K, et al
   Randomised phase II trial of trifluridine/tipiracil (FTD/TPI) plus ramucirumab (RAM) versus trifluridine/tipiracil for previously treated patients with advanced gastric or esophagogastric junction adenocarcinoma (RETRIEVE study, WJOG15822G).
   BMC Cancer. 2023;23:726.
   

   >> Share

   
   

   
   BMC Surg

2. ZHU G, Lang X, Zhou S, Li B, et al
   Short- and long-term outcomes of single-port versus multiport laparoscopic radical gastrectomy for gastric cancer: a meta-analysis of propensity score-matched studies and randomized controlled trials.
   BMC Surg. 2023;23:223.
   

   >> Share

   
   
3. ERGENC M, Uprak TK, Akin MI, Hekimoglu EE, et al
   Prognostic significance of metastatic lymph node ratio in gastric cancer: a Western-center analysis.
   BMC Surg. 2023;23:220.
   

   >> Share

   
   

   
   Cancer Lett

4. ANDREUCCI E, Biagioni A, Peri S, Versienti G, et al
   The CAIX inhibitor SLC-0111 exerts anti-cancer activity on gastric cancer cell lines and resensitizes resistant cells to 5-Fluorouracil, taxane-derived, and platinum-based drugs.
   Cancer Lett. 2023 Aug 5:216338. doi: 10.1016/j.canlet.2023.216338.
   

   >> Share

   
   

   
   Int J Cancer

5. CAO F, Sun H, Yang Z, Bai Y, et al
   Multiple approaches revealed MGc80-3 as a somatic hybrid with HeLa cells rather than a gastric cancer cell line.
   Int J Cancer. 2023 Aug 6. doi: 10.1002/ijc.34677.
   

   >> Share

   
   

   
   Minerva Surg

6. CHI WC, Jiang QH, Jiang JK, Ma BZ, et al
   Progress in traditional Chinese medicine treatment of cancer-related fatigue in gastric cancer.
   Minerva Surg. 2023 Aug 4. doi: 10.23736/S2724-5691.23.09983.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share